{
    "code": "10000525",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000525",
    "time": "2023-10-06 13:08:29",
    "許可證字號": "衛署菌疫輸字第000525號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/20",
    "發證\/登錄日期": "88\/04\/20",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000052509",
    "中文品名": "保妥適乾粉注射劑",
    "英文品名": "BOTOX (BOTULINUM TOXIN TYPE A) PURIFIED NEUROTOXIN COMPLEX",
    "適應症": "眼瞼痙攣、半面痙攣、局部肌肉痙攣症、斜視、痙攣性斜頸、小兒腦性痲痹引起之肌肉痙攣。上臉部皺紋(皺眉紋、抬頭紋、魚尾紋)、原發性腋窩多汗症。成人中風後之手臂痙攣。因脊髓病變所引起的逼尿肌過動而導致尿失禁之成人病患，且經抗膽鹼類藥物治療無效或無法耐受者。治療有尿失禁、尿急與頻尿等膀胱過動症的成人病患，經抗膽鹼類藥物治療反應不佳或無法耐受必須停藥，且如有需要時，願意及能夠於治療後進行乾淨間歇性導尿(Clean intermittent catheterization) 者。BOTOX適用於慢性偏頭痛 (至少有3個月時間，每個月≧15天，每次持續4小時以上，且其中至少有一半的頭痛是偏頭痛) 成人病患的頭痛預防性治療。[重要限制：BOTOX對陣發性頭痛(每月頭痛天數≤14天)之安全性及有效性尚無證據證明。] 治療成人病患之下肢痙攣， 以減少踝關節和腳趾屈肌群( 腓腸肌、比目魚肌、脛後肌、屈拇長肌和屈趾長肌)肌張力增加的嚴重程度。",
    "劑型": "240乾粉注射劑",
    "包裝": "50、100、200單位小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "類毒素;",
    "監視期限": "",
    "主成分略述": "BOTULINUM TOXIN TYPE A",
    "限制項目": "02輸　入",
    "申請商名稱": "瑞士商艾伯維藥品有限公司台灣分公司",
    "申請商地址": "臺北市中山區民生東路3段49、51號15樓",
    "主製造廠": [
        {
            "製造廠名稱": "ALLERGAN PHARMACEUTICALS IRELAND",
            "製造廠廠址": "CASTLEBAR ROAD, WESTPORT  COUNTY  MAYO,IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "Allergan Sales LLC",
            "製造廠廠址": "503 Vandell Way, Suite E, Campbell, California 95008, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "30029090905 人類血液；已調製動物血液供治療、預防疾病或診斷用；毒素、微生物培養體（酵母除外）和類似品Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; toxins, cultures of micro-organisms (excluding yeasts) and similar products",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1220002600",
            "成分名稱": "BOTULINUM TOXIN TYPE A",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "U (UNIT)"
        }
    ],
    "仿單外盒": [
        {
            "title": "010005250001-仿單-109-07-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000525&Seq=028&Type=9"
        },
        {
            "title": "100005250004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000525&Seq=010&Type=8"
        }
    ]
}